InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Allen Andrew R, Chairman & CEO. Director active across 3 companies, notably Epizyme, Inc.. Aggregated, 10 filings have been logged. History available since 11 June 2021. The latest transaction was disclosed on 24 June 2024 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
325,000 shares0Common StockSEC:0001415889-24-018275:0
47,873 shares0Common StockSEC:0001415889-24-013657:0
105,000 shares0Common StockSEC:0001415889-24-002702:0
738,550 shares0Common StockSEC:0001567619-23-001941:0
1,650 shares@ US$55.00100.0% of flowCommon StockSEC:0001209191-22-040258:0
70,000 shares0Common StockSEC:0001567619-22-008708:0
48,200 shares0Common StockSEC:0001567619-21-020853
48,200 shares0Common StockSEC:0001567619-21-020853:0
8,060 shares0Common Stock, par value $0.0001SEC:0000899243-21-023872
8,060 shares0Common Stock, par value $0.0001SEC:0000899243-21-023872:0
10 of 10 declarations
About Allen Andrew R
Allen Andrew R is the President and CEO of Epizyme, Inc., Gritstone bio, Inc., and Sierra Oncology, Inc. He leads the operations and strategy of these companies, ensuring their growth and success. His leadership and vision are essential for achieving the objectives of each company. Andrew is committed to promoting innovation and excellence in the biopharmaceutical sector.
